Annual Current Assets
$237.43 M
-$26.17 M-9.93%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual total current assets is currently $237.43 million, with the most recent change of -$26.17 million (-9.93%) on 31 December 2023. During the last 3 years, it has fallen by -$263.13 million (-52.57%). LGND annual current assets is now -78.87% below its all-time high of $1.12 billion, reached on 31 December 2019.LGND Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$309.39 M
-$2.87 M-0.92%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly total current assets is currently $309.39 million, with the most recent change of -$2.87 million (-0.92%) on 30 September 2024. Over the past year, it has increased by +$55.39 million (+21.81%). LGND quarterly current assets is now -82.27% below its all-time high of $1.75 billion, reached on 30 September 2018.LGND Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.9% | +21.8% |
| 3 y3 years | -52.6% | -28.4% |
| 5 y5 years | -72.7% | -73.8% |
LGND Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -52.6% | at low | -33.4% | +40.4% |
| 5 y | 5 years | -78.9% | at low | -73.8% | +40.4% |
| alltime | all time | -78.9% | +896.6% | -82.3% | +2023.5% |
Ligand Pharmaceuticals Incorporated Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $309.39 M(-0.9%) |
| June 2024 | - | $312.26 M(-15.4%) |
| Mar 2024 | - | $368.91 M(+55.4%) |
| Dec 2023 | $549.79 M(+10.2%) | $237.43 M(-6.5%) |
| Sept 2023 | - | $253.99 M(-8.2%) |
| June 2023 | - | $276.71 M(-15.7%) |
| Mar 2023 | - | $328.19 M(+24.5%) |
| Dec 2022 | $499.07 M(-40.1%) | $263.60 M(+19.6%) |
| Sept 2022 | - | $220.43 M(-9.6%) |
| June 2022 | - | $243.78 M(-11.7%) |
| Mar 2022 | - | $276.07 M(-40.6%) |
| Dec 2021 | $832.84 M(-3.4%) | $464.75 M(+7.6%) |
| Sept 2021 | - | $432.08 M(+5.2%) |
| June 2021 | - | $410.90 M(-6.1%) |
| Mar 2021 | - | $437.43 M(-12.6%) |
| Dec 2020 | $861.73 M(+132.1%) | $500.56 M(-41.6%) |
| Sept 2020 | - | $857.74 M(-0.7%) |
| June 2020 | - | $863.62 M(+4.0%) |
| Mar 2020 | - | $830.73 M(-26.1%) |
| Dec 2019 | $371.27 M(-4.9%) | $1.12 B(-5.0%) |
| Sept 2019 | - | $1.18 B(-18.0%) |
| June 2019 | - | $1.44 B(-8.0%) |
| Mar 2019 | - | $1.57 B(+80.1%) |
| Dec 2018 | $390.26 M(-10.1%) | $870.54 M(-50.1%) |
| Sept 2018 | - | $1.75 B(+17.9%) |
| June 2018 | - | $1.48 B(+324.1%) |
| Mar 2018 | - | $349.05 M(+47.3%) |
| Dec 2017 | $434.00 M(-1.0%) | $237.02 M(+5.7%) |
| Sept 2017 | - | $224.20 M(+13.7%) |
| June 2017 | - | $197.18 M(+12.9%) |
| Mar 2017 | - | $174.70 M(+7.1%) |
| Dec 2016 | $438.53 M(+52.1%) | $163.05 M(+15.9%) |
| Sept 2016 | - | $140.69 M(+11.2%) |
| June 2016 | - | $126.56 M(-4.9%) |
| Mar 2016 | - | $133.06 M(-38.0%) |
| Dec 2015 | $288.35 M(+295.7%) | $214.71 M(+2.1%) |
| Sept 2015 | - | $210.32 M(+6.9%) |
| June 2015 | - | $196.72 M(+2.6%) |
| Mar 2015 | - | $191.71 M(+3.5%) |
| Dec 2014 | $72.87 M(-8.7%) | $185.16 M(-6.7%) |
| Sept 2014 | - | $198.52 M(+594.5%) |
| June 2014 | - | $28.59 M(-14.4%) |
| Mar 2014 | - | $33.40 M(+34.3%) |
| Dec 2013 | $79.83 M(-0.8%) | $24.88 M(+49.6%) |
| Sept 2013 | - | $16.64 M(+14.2%) |
| June 2013 | - | $14.57 M(-17.9%) |
| Mar 2013 | - | $17.74 M(-25.5%) |
| Dec 2012 | $80.44 M(-9.0%) | $23.82 M(+36.6%) |
| Sept 2012 | - | $17.43 M(-17.4%) |
| June 2012 | - | $21.10 M(-10.4%) |
| Mar 2012 | - | $23.54 M(-27.0%) |
| Dec 2011 | $88.35 M(+129.3%) | $32.23 M(+20.2%) |
| Sept 2011 | - | $26.82 M(-4.7%) |
| June 2011 | - | $28.14 M(-10.1%) |
| Mar 2011 | - | $31.30 M(-15.5%) |
| Dec 2010 | $38.54 M(-47.7%) | $37.02 M(+4.9%) |
| Sept 2010 | - | $35.29 M(-18.7%) |
| June 2010 | - | $43.40 M(-13.9%) |
| Mar 2010 | - | $50.39 M(-26.1%) |
| Dec 2009 | $73.64 M | $68.17 M(+13.8%) |
| Sept 2009 | - | $59.90 M(-13.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $69.47 M(+2.6%) |
| Mar 2009 | - | $67.69 M(-27.9%) |
| Dec 2008 | $77.52 M(+22.4%) | $93.93 M(+9.3%) |
| Sept 2008 | - | $85.97 M(-10.6%) |
| June 2008 | - | $96.11 M(-5.7%) |
| Mar 2008 | - | $101.90 M(-7.3%) |
| Dec 2007 | $63.34 M(-30.0%) | $109.94 M(-5.0%) |
| Sept 2007 | - | $115.78 M(-12.4%) |
| June 2007 | - | $132.18 M(-69.1%) |
| Mar 2007 | - | $427.95 M(+81.7%) |
| Dec 2006 | $90.50 M(-50.2%) | $235.56 M(+265.1%) |
| Sept 2006 | - | $64.53 M(-43.3%) |
| June 2006 | - | $113.90 M(+1.4%) |
| Mar 2006 | - | $112.34 M(-15.5%) |
| Dec 2005 | $181.65 M(+10.6%) | $132.97 M(+13.0%) |
| Sept 2005 | - | $117.71 M(+8.4%) |
| June 2005 | - | $108.54 M(-17.6%) |
| Mar 2005 | - | $131.70 M(-21.7%) |
| Dec 2004 | $164.26 M(-4.1%) | $168.21 M(+34.2%) |
| Sept 2004 | - | $125.33 M(+5.5%) |
| June 2004 | - | $118.81 M(-4.9%) |
| Mar 2004 | - | $124.90 M(-12.5%) |
| Dec 2003 | $171.27 M(-8.3%) | $142.78 M(+34.9%) |
| Sept 2003 | - | $105.86 M(+85.8%) |
| June 2003 | - | $56.97 M(-9.6%) |
| Mar 2003 | - | $63.01 M(-28.9%) |
| Dec 2002 | $186.86 M(+192.4%) | $88.57 M(+83.5%) |
| Sept 2002 | - | $48.27 M(-21.2%) |
| June 2002 | - | $61.22 M(+19.7%) |
| Mar 2002 | - | $51.15 M(-4.5%) |
| Dec 2001 | $63.90 M(-7.1%) | $53.57 M(+3.0%) |
| Sept 2001 | - | $52.03 M(-9.6%) |
| June 2001 | - | $57.58 M(-0.1%) |
| Mar 2001 | - | $57.61 M(+29.0%) |
| Dec 2000 | $68.77 M(-11.7%) | $44.65 M(+1.4%) |
| Sept 2000 | - | $44.04 M(-20.7%) |
| June 2000 | - | $55.51 M(-5.0%) |
| Mar 2000 | - | $58.41 M(+3.0%) |
| Dec 1999 | $77.90 M(-0.1%) | $56.70 M(+3.7%) |
| Sept 1999 | - | $54.70 M(+23.8%) |
| June 1999 | - | $44.20 M(-24.2%) |
| Mar 1999 | - | $58.30 M(-25.3%) |
| Dec 1998 | $78.00 M(+234.8%) | $78.00 M(+69.6%) |
| Sept 1998 | - | $46.00 M(-12.0%) |
| June 1998 | - | $52.30 M(-18.0%) |
| Mar 1998 | - | $63.80 M(-24.1%) |
| Dec 1997 | $23.30 M(+39.5%) | $84.10 M(+53.5%) |
| Sept 1997 | - | $54.80 M(-14.9%) |
| June 1997 | - | $64.40 M(-15.2%) |
| Mar 1997 | - | $75.90 M(-11.1%) |
| Dec 1996 | $16.70 M(-18.9%) | $85.40 M(+67.8%) |
| Sept 1996 | - | $50.90 M(-14.5%) |
| June 1996 | - | $59.50 M(-12.2%) |
| Mar 1996 | - | $67.80 M(-7.1%) |
| Dec 1995 | $20.60 M(+303.9%) | $73.00 M(-1.4%) |
| Sept 1995 | - | $74.00 M(+85.5%) |
| Mar 1995 | - | $39.90 M(-4.1%) |
| Dec 1994 | $5.10 M | $41.60 M(-11.1%) |
| Sept 1994 | - | $46.80 M(+49.5%) |
| June 1994 | - | $31.30 M(-18.9%) |
| Mar 1994 | - | $38.60 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual total current assets?
- What is the all time high annual current assets for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual current assets year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly total current assets?
- What is the all time high quarterly current assets for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly current assets year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual total current assets?
The current annual current assets of LGND is $237.43 M
What is the all time high annual current assets for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual total current assets is $1.12 B
What is Ligand Pharmaceuticals Incorporated annual current assets year-on-year change?
Over the past year, LGND annual total current assets has changed by -$26.17 M (-9.93%)
What is Ligand Pharmaceuticals Incorporated quarterly total current assets?
The current quarterly current assets of LGND is $309.39 M
What is the all time high quarterly current assets for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly total current assets is $1.75 B
What is Ligand Pharmaceuticals Incorporated quarterly current assets year-on-year change?
Over the past year, LGND quarterly total current assets has changed by +$55.39 M (+21.81%)